"May you live in interesting times" rather sums up 2020. It has been and still is a roller-coaster ride, due to a speck of genetic material that does not satisfy the basic requirements for 'being alive'. The good news is that we are adapting, and hopefully will invest in becoming more resilient in the future.
In spite of covid-19, we are making progress. The "Industry Expectations" team has met regularly via Zoom to figure out how we can bridge what business/industry is looking for and what biom* can deliver. One of the focus areas next year is an end-to-end look at biom*:
Once we figure out what the questions are, we will engage the BID Community to look for answers.